Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections [LYTICS +]
Recruiting now · Phase 2
Conditions studied: Pleural Effusion Associated With Pulmonary Infection, Pleural Effusion Disorder, Pleural Effusions
In brief
The purpose of this protocol is to conduct a pilot prospective non-blind clinical trial to evaluate the efficacy and safety of a novel saline irrigation technique as an adjunct to standard interventions for treating retained pleural infections. Intrapleural fibrinolytic therapy (IPFT) is commonly used for infections not adequately managed with antibiotics and intercostal tube drainage, while saline irrigation serves as an alternative for cases with a high bleeding risk where IPFT is not feasible. The efficacy of saline irrigation combined with IPFT remains unexplored. The hypothesis is that saline irrigation could be an effective and safe addition to IPFT for patients with persistent pleural infections. The specific aims of the study include: Determine the efficacy of saline irrigation as add-on therapy to IPFT: Compare the clinical outcomes of patients receiving saline irrigation combined with IPFT to those receiving IPFT alone to determine if the addition of saline irrigation offers significant benefits. Outcomes include changes in inflammatory markers, imaging characteristics (echography and CT), volume of pleural fluid drained, chest tube duration, hospital length of stay, and the need for subsequent surgical intervention. Assess the safety and tolerability of saline irrigation plus IPFT: Compare complications and patient comfort in those receiving saline irrigation combined with IPFT to those receiving IPFT alone.
Key facts
- Study ID
- NCT06713382
- Run by
- Beth Israel Deaconess Medical Center
- People needed
- 96
- Starts
- 2025-04-10
- Expected to finish
- 2026-12-20
- Last updated by the study team
- 2025-05-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years.
- Presence of purulent pleural fluid or pleural fluid analysis with any of the following:
- pH ≤ 7.2.
- Glucose < 40 mg/dL.
- LDH > 1000 IU/L.
- Presence of bacterial or fungal organisms on Gram stain or culture.
- Chest tube placement with less than 200 mL drainage in 24 hours.
- Indication for IPFT treatment based on treating physician's criteria.
- Radiographic evidence of septations on chest ultrasound (US) or loculations on low-dose chest computed tomography (CT).
You may not qualify if…
- Inability to provide informed consent.
- Pregnant patients.
- Patients with significant comorbidities that may interfere with the study -outcomes (e.g., terminal malignancy).
- Complicated sympathetic effusion.
- Hepatic hydrothorax.
Where it is running
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.